XY0YX37Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7
- Billable / Specific Code
XY0YX37 is a billable ICD-10-PCS procedure code for Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | Y | Extracorporeal |
| 3 | Operation | 0 | Introduction |
| 4 | BodyPart | Y | Extracorporeal |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | 3 | Nafamostat Anticoagulant |
| 7 | Qualifier | 7 | New Technology Group 7 |
Similar Procedure Codes
Questions About XY0YX37
Is XY0YX37 a billable code?
Yes. XY0YX37 is a complete seven-character ICD-10-PCS code, specific enough to report Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XY0YX37 mean?
XY0YX37 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character Y is the Body System (Extracorporeal); the 3rd character 0 is the Operation (Introduction); the 4th character Y is the BodyPart (Extracorporeal); the 5th character X is the Approach (External); the 6th character 3 is the Device/Substance/Technology (Nafamostat Anticoagulant); the 7th character 7 is the Qualifier (New Technology Group 7).
